424 related articles for article (PubMed ID: 22288877)
1. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men.
Dinsmore WW; Wyllie MG
BJU Int; 2012 Jul; 110(2):162-9. PubMed ID: 22288877
[TBL] [Abstract][Full Text] [Related]
2. Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism.
Korbonits M; Kipnes M; Grossman AB
Int J Clin Pract; 2004 Nov; 58(11):1073-80. PubMed ID: 15605676
[TBL] [Abstract][Full Text] [Related]
3. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.
Wang C; Swerdloff R; Kipnes M; Matsumoto AM; Dobs AS; Cunningham G; Katznelson L; Weber TJ; Friedman TC; Snyder P; Levine HL
J Clin Endocrinol Metab; 2004 Aug; 89(8):3821-9. PubMed ID: 15292312
[TBL] [Abstract][Full Text] [Related]
4. A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.
Korbonits M; Slawik M; Cullen D; Ross RJ; Stalla G; Schneider H; Reincke M; Bouloux PM; Grossman AB
J Clin Endocrinol Metab; 2004 May; 89(5):2039-43. PubMed ID: 15126518
[TBL] [Abstract][Full Text] [Related]
5. Testosterone undecanoate in the treatment of male hypogonadism.
Edelstein D; Basaria S
Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
[TBL] [Abstract][Full Text] [Related]
6. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men.
Ross RJ; Jabbar A; Jones TH; Roberts B; Dunkley K; Hall J; Long A; Levine H; Cullen DR
Eur J Endocrinol; 2004 Jan; 150(1):57-63. PubMed ID: 14713280
[TBL] [Abstract][Full Text] [Related]
8. Testosterone treatment comes of age: new options for hypogonadal men.
Nieschlag E
Clin Endocrinol (Oxf); 2006 Sep; 65(3):275-81. PubMed ID: 16918944
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
11. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men.
Wang C; Ilani N; Arver S; McLachlan RI; Soulis T; Watkinson A
Clin Endocrinol (Oxf); 2011 Dec; 75(6):836-43. PubMed ID: 21689131
[TBL] [Abstract][Full Text] [Related]
13. Testosterone-buccal--Columbia: COL 1621, Striant, testosterone PHBT, testosterone progressive hydration buccal tablet.
Drugs R D; 2003; 4(1):72-4. PubMed ID: 12568644
[No Abstract] [Full Text] [Related]
14. Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men.
Dobs AS; Matsumoto AM; Wang C; Kipnes MS
Curr Med Res Opin; 2004 May; 20(5):729-38. PubMed ID: 15140340
[TBL] [Abstract][Full Text] [Related]
15. Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men.
Meikle AW; Matthias D; Hoffman AR
BJU Int; 2004 Apr; 93(6):789-95. PubMed ID: 15049991
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Raynaud JP; Gardette J; Rollet J; Legros JJ
BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment patterns of testosterone replacement medications.
Donatucci C; Cui Z; Fang Y; Muram D
J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents.
Seftel A
Int J Impot Res; 2007; 19(1):2-24. PubMed ID: 16193074
[TBL] [Abstract][Full Text] [Related]
19. Testosterone supplementation: what and how to give.
Jockenhövel F
Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
[TBL] [Abstract][Full Text] [Related]
20. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
Kaminetsky JC; Moclair B; Hemani M; Sand M
J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
